HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by JIMÉNEZ-CHILLARÓN, J. C. Articles by GÓMEZ-FOIX, A. M. Search for Related Content PubMed PubMed Citation Articles by JIMÉNEZ-CHILLARÓN, J. C. Articles by GÓMEZ-FOIX, A. M.

Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo

Departament de Bioquímica i Biologia Molecular, Universitat de Barcelona, Martí i Franquès, 1, 08028 Barcelona, Spain; and
^* Departments of Biochemistry and Internal Medicine and Gifford Laboratories for Diabetes Research, University of Texas Southwestern Medical Center, Dallas, Texas 75235, USA

¹Correspondence: Departament de Bioquímica i Biologia Molecular, Facultat de Química, Universitat de Barcelona, Martí i Franquès, 1, 08028-Barcelona, Spain. E-mail: anamaria{at}sun.bq.ub.es

In non-insulin-dependent diabetes mellitus, insulin-stimulated glucose uptake is impaired in muscle, contributing in a major way to development of hyperglycemia. We previously showed that expression of the glucose phosphorylating enzyme glucokinase (GK) in cultured human myocytes improved glucose storage and disposal, suggesting that GK delivery to muscle in situ could potentially enhance glucose clearance. Here we have tested this idea directly by intramuscular delivery of an adenovirus containing the liver GK cDNA (AdCMV-GKL) into one hind limb. We injected an adenovirus containing the ß-galactosidase gene (AdCMV-lacZ) into the hind limb of newborn rats. ß-Galactosidase activity was localized in muscle for as long as 1 month after delivery, with a large percentage of fibers staining positive in the gastrocnemius. Using the same approach with AdCMV-GKL, GK protein content was increased from zero to 50–400% of the GK in normal liver sample, and total glucose phosphorylating activity was increased in GK-expressing muscles relative to the counterpart uninfected muscle. Expression of GK in muscle improved glucose tolerance rather than changing basal glycemic control. Glucose levels were reduced by ~35% 10 min after administration of a glucose bolus to fed animals treated with AdCMV-GKL relative to AdCMV-lacZ-treated controls. The enhanced rate of glucose clearance was reflected in increases in muscle 2-deoxy glucose uptake and blood lactate levels. We conclude that restricted expression of GK in muscle leads to an enhanced capacity for muscle glucose disposal and whole body glucose tolerance under conditions of maximal glucose-insulin stimulation, suggesting that under these conditions glucose phosphorylation becomes rate-limiting. Our findings also show that gene delivery to a fraction of the whole body is sufficient to improve glucose disposal, providing a rationale for the development of new therapeutic strategies for treatment of diabetes.—Jiménez-Chillarón, J. C., Newgard, C. B., Gómez-Foix, A. M. Increased glucose disposal induced by adenovirus-mediated transfer of glucokinase to skeletal muscle in vivo.

Key Words: glucose phosphorylating activity • glucokinase expression • GLUT4 expression • non-insulin-dependent diabetes mellitus

This article has been cited by other articles:

				A. Mas, J. Montane, X. M. Anguela, S. Munoz, A. M. Douar, E. Riu, P. Otaegui, and F. Bosch Reversal of Type 1 Diabetes by Engineering a Glucose Sensor in Skeletal Muscle Diabetes, June 1, 2006; 55(6): 1546 - 1553. [Abstract] [Full Text] [PDF]

				N. Fujii, M. D. Boppart, S. D. Dufresne, P. F. Crowley, A. C. Jozsi, K. Sakamoto, H. Yu, W. G. Aschenbach, S. Kim, H. Miyazaki, et al. Overexpression or ablation of JNK in skeletal muscle has no effect on glycogen synthase activity Am J Physiol Cell Physiol, July 1, 2004; 287(1): C200 - C208. [Abstract] [Full Text] [PDF]

				Q. Liang, R. V Donthi, P. M Kralik, and P. N Epstein Elevated hexokinase increases cardiac glycolysis in transgenic mice Cardiovasc Res, February 1, 2002; 53(2): 423 - 430. [Abstract] [Full Text] [PDF]

				U. J. Desai, E. D. Slosberg, B. R. Boettcher, S. L. Caplan, B. Fanelli, Z. Stephan, V. J. Gunther, M. Kaleko, and S. Connelly Phenotypic Correction of Diabetic Mice by Adenovirus-Mediated Glucokinase Expression Diabetes, October 1, 2001; 50(10): 2287 - 2295. [Abstract] [Full Text]

				E. D. Slosberg, U. J. Desai, B. Fanelli, I. St. Denny, S. Connelly, M. Kaleko, B. R. Boettcher, and S. L. Caplan Treatment of Type 2 Diabetes by Adenoviral-Mediated Overexpression of the Glucokinase Regulatory Protein Diabetes, August 1, 2001; 50(8): 1813 - 1820. [Abstract] [Full Text] [PDF]